WallStreetZenWallStreetZen

NYSE: CTLT
Catalent Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for CTLT

Based on 7 analysts offering 12 month price targets for Catalent Inc.
Min Forecast
$105.00+44.35%
Avg Forecast
$117.86+62.03%
Max Forecast
$125.00+71.84%

Should I buy or sell CTLT stock?

Based on 7 analysts offering ratings for Catalent Inc.
Strong Buy
Strong Buy
5 analysts 71.43%
Buy
1 analysts 14.29%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CTLT stock forecasts and price targets.

CTLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Jefferies
Top 3%
98
Strong BuyMaintains$110.00+51.22%2022-08-30
Morgan Stanley
Bottom 7%
7
Strong BuyMaintains$120.00+64.97%2022-08-30
Deutsche Bank
Bottom 27%
27
HoldMaintains$105.00+44.35%2022-08-30
RBC Capital
Top 38%
63
BuyMaintains$125.00+71.84%2022-08-30
Bank of America
Top 6%
95
Strong BuyMaintains$125.00+71.84%2022-08-30
Barclays
Bottom 7%
7
Strong BuyMaintains$115.00+58.10%2022-08-30
KeyBanc
Top 14%
87
Strong BuyMaintains$125.00+71.84%2022-05-04
Anonymous
Morgan Stanley
Strong BuyMaintains$145.00+99.34%2022-02-02

1 of 1

Forecast return on equity

Is CTLT forecast to generate an efficient return?
Company
20.97%
Industry
20.85%
Market
119.16%
CTLT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CTLT forecast to generate an efficient return on assets?
Company
9.57%
Industry
13.86%
CTLT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CTLT earnings per share forecast

What is CTLT's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$3.99+40%
Avg 2 year Forecast
$4.69+64.56%
Avg 3 year Forecast
$5.59+96.14%
CTLT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CTLT revenue forecast

What is CTLT's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$5.3B+9.31%
Avg 2 year Forecast
$5.8B+19.63%
Avg 3 year Forecast
$6.5B+34.09%
CTLT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CTLT earnings growth forecast

How is CTLT forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
23.67%
Industry
15.95%
Market
16.69%
CTLT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CTLT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CTLT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CTLT revenue growth forecast

How is CTLT forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
9.75%
Industry
6.16%
Market
8.53%
CTLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CTLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CTLT vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CTLT$72.74$117.86+62.03%Strong Buy
VTRS$8.48$11.80+39.15%Sell
TEVA$7.74$10.60+36.95%Hold
RDY$50.55$69.00+36.50%Strong Buy
ELAN$12.79$20.40+59.50%Hold
View Top Pharmaceutical Stocks

Catalent Stock Forecast FAQ

Is Catalent Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: CTLT) stock is to Strong Buy CTLT stock.

Out of 7 analysts, 5 (71.43%) are recommending CTLT as a Strong Buy, 1 (14.29%) are recommending CTLT as a Buy, 1 (14.29%) are recommending CTLT as a Hold, 0 (0%) are recommending CTLT as a Sell, and 0 (0%) are recommending CTLT as a Strong Sell.

If you're new to stock investing, here's how to buy Catalent stock.

What is CTLT's earnings growth forecast for 2023-2025?

(NYSE: CTLT) Catalent's forecast annual earnings growth rate of 23.67% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 15.95%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.69%.

Catalent's earnings in 2022 is $503,000,000.On average, 7 Wall Street analysts forecast CTLT's earnings for 2023 to be $717,783,751, with the lowest CTLT earnings forecast at $694,397,313, and the highest CTLT earnings forecast at $748,366,016. On average, 2 Wall Street analysts forecast CTLT's earnings for 2024 to be $843,710,725, with the lowest CTLT earnings forecast at $820,324,287, and the highest CTLT earnings forecast at $867,097,163.

In 2025, CTLT is forecast to generate $1,005,616,834 in earnings, with the lowest earnings forecast at $1,005,616,834 and the highest earnings forecast at $1,005,616,834.

What is CTLT's revenue growth forecast for 2023-2025?

(NYSE: CTLT) Catalent's forecast annual revenue growth rate of 9.75% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.16%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.53%.

Catalent's revenue in 2022 is $4,828,000,000.On average, 6 Wall Street analysts forecast CTLT's revenue for 2023 to be $949,383,424,652, with the lowest CTLT revenue forecast at $937,256,477,170, and the highest CTLT revenue forecast at $964,726,547,048. On average, 4 Wall Street analysts forecast CTLT's revenue for 2024 to be $1,039,021,662,692, with the lowest CTLT revenue forecast at $1,011,913,183,125, and the highest CTLT revenue forecast at $1,060,341,099,373.

In 2025, CTLT is forecast to generate $1,164,644,612,898 in revenue, with the lowest revenue forecast at $1,164,644,612,898 and the highest revenue forecast at $1,164,644,612,898.

What is CTLT's forecast return on assets (ROA) for 2023-2025?

(NYSE: CTLT) forecast ROA is 9.57%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.86%.

What is CTLT's Price Target?

According to 7 Wall Street analysts that have issued a 1 year CTLT price target, the average CTLT price target is $117.86, with the highest CTLT stock price forecast at $125.00 and the lowest CTLT stock price forecast at $105.00.

On average, Wall Street analysts predict that Catalent's share price could reach $117.86 by Aug 30, 2023. The average Catalent stock price prediction forecasts a potential upside of 62.03% from the current CTLT share price of $72.74.

What is CTLT's Earnings Per Share (EPS) forecast for 2023-2025?

(NYSE: CTLT) Catalent's current Earnings Per Share (EPS) is $2.85. On average, analysts forecast that CTLT's EPS will be $3.99 for 2023, with the lowest EPS forecast at $3.86, and the highest EPS forecast at $4.16. On average, analysts forecast that CTLT's EPS will be $4.69 for 2024, with the lowest EPS forecast at $4.56, and the highest EPS forecast at $4.82. In 2025, CTLT's EPS is forecast to hit $5.59 (min: $5.59, max: $5.59).

What is CTLT's forecast return on equity (ROE) for 2023-2025?

(NYSE: CTLT) forecast ROE is 20.97%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.